Cluster headaches are also known as Horton’s syndrome. TACs (Trigeminal autonomic cephalgia), the major kind of headache, are most frequently manifested as cluster headaches. As just 0.1 percent of the population suffers from them, it is at best challenging to investigate the disease process. Considering their rarity, they should always be recognized and treated because they have established a reputation as being one of, but not the most serious forms of headaches.
Given that FDR (first-degree relatives) had an 18-fold increased risk of being diagnosed with Horton’s syndrome, there is some evidence of genetic correlation. Uncertainty surrounds the inheritance mode, though. While a few families appear to transmit the symptoms down in an autosomal dominant pattern, others appear to do so.
A single headache with at minimum one ipsilateral autonomic sign qualifies as a cluster headache. Up to 8 times per day, such headaches can happen every other day. They typically happen around the same hour of the day, most frequently during the night. The majority of patients experience repeated attacks for days to months at a time, accompanied by remissions lasting months or even years.
Epidemiology
0.1 percent of the population in general experiences cluster headaches. Though it can begin at any age, the average age of onset is around 30. Although a recent study has revealed that the proportion has been declining with time, men are 3 times as likely as women to experience this illness.
This occurrence may be attributable to increased diagnostic performance; frequently, Horton’s syndrome is misdiagnosed in women as migraines. It’s interesting to note that tobacco users make up 85% of all cluster headache sufferers.
If a patient has a first-degree family who has been diagnosed with cluster headaches, their chances of getting one are increased by eighteen times. According to a wide range of research, between thirty and eighty percent of those who suffer from Horton’s syndrome have already sleep apnea.
Anatomy
Pathophysiology
Horton’s syndrome can have several different causes, as was already mentioned. There seems to be a diurnal regularity, which prompts research into the hypothalamus and, ultimately, morphological studies that reveal anomalies. The trigeminovascular network and parasympathetic nerve fibers are also involved.
Some studies have hypothesized that instability of the autonomic nervous system and a deficiency in the central route of pain control cause problems in the supraspinal control of cognitive processing and pain. Investigators also have discovered abnormalities in the GABA, ion channel, as well as inflammation-related molecular signaling pathways, particularly histamine, cell surface proteins, and Interleukin-2.
Given that pituitary adenylate cyclase-activating polypeptide (PCAP), rises in the blood throughout attacks, genetic testing has identified a number of potential sources, such as Period circadian protein homolog 3 protein (related to the circadian clock), orexin-B (related to the sleep-wake routine, modulation of nociceptive neurotransmission, and food consumption), and pituitary adenylate cyclase-activating Polypeptide receptor allele. All proposed genetic routes require further investigation.
Etiology
Horton’s syndrome has an unclear cause. Numerous hypotheses have been put out and investigated. Sadly, sample sizes are constrained because people with this illness are rather uncommon. The parasympathetic nervous system responsible for the trigeminal-autonomic reflex pathway, the hypothalamus region, and the trigeminovascular system, are all known to be connected.
It is unclear how these components interact to produce severe headaches, though. The genetics of the illness has also been extensively studied, leading to a biochemical evaluation, because there is a clear genetic connection. A painful attack and vasodilation are inextricably linked. Perivascular sensory neurons generate widening of blood vessels (vasodilation) when the trigeminovascular system is activated.
The trigeminal nerve terminal is thought to be unilaterally activated; however functional MRI hasn’t shown this to be the case. Additionally, the number or duration of attacks is unaffected by a complete trigeminal nerve root division. This lack of improvement only demonstrates that there are other components to the cluster headache; it does not exclude the trigeminovascular system as a contributing factor.
Horton’s syndromes are definitely linked to the hypothalamic. Attacks occur most frequently at night and provide a circadian regularity. When the patient is experiencing an attack, PET (positron emission tomography) scans have revealed activity of the inferior hypothalamus grey volume. Studies on morphology have revealed anatomic irregularities in the same hypothalamic area.
However, it should be noted that activation of the hypothalamic does not cause attacks. Also, some studies point to the possibility that stimulating the hypothalamus could stop an attack.
The parasympathetic nerve fibers, which are a component of the trigeminal autonomic response, are what trigger the autonomic signs, such as rhinorrhea, lacrimation, and facial vasodilation. Similar to the hypothalamic, it is a well-known contributor to cluster headaches, however, it is unclear what causes the trigeminal reflex to activate.
Risk elements:
Gender male
Older than 30 years old
Alcohol consumption
Previous brain injury or surgery
Genetics
Prognostic Factors
Approximately twenty-five percent of people who get a cluster headache never get another one. About fifteen to twenty percent of individuals will experience chronic cluster headaches, and ten to twenty percent of these patients will become medication-resistant resistant. Usually, it takes this ailment fifteen years to get well.
Patients may suffer harm to their mental well-being. Physical burdens and a decline in quality of life will result. Suicidal ideation is frequently reported by patients, but actual action is uncommon.
Initial dose: 300mg subcutaneous at the onset of cluster headache
Maintenance dose: 300mg subcutaneously monthly once until the end of cluster headaches
Dose Adjustments
Hepatic impairment
No dedicated studies have been conducted to specifically evaluate the effects of hepatic impairment on the pharmacokinetics of galcanezumab
Renal impairment
No dedicated studies have been conducted to specifically evaluate the effects of hepatic impairment on the pharmacokinetics of galcanezumab
Cluster headaches are also known as Horton’s syndrome. TACs (Trigeminal autonomic cephalgia), the major kind of headache, are most frequently manifested as cluster headaches. As just 0.1 percent of the population suffers from them, it is at best challenging to investigate the disease process. Considering their rarity, they should always be recognized and treated because they have established a reputation as being one of, but not the most serious forms of headaches.
Given that FDR (first-degree relatives) had an 18-fold increased risk of being diagnosed with Horton’s syndrome, there is some evidence of genetic correlation. Uncertainty surrounds the inheritance mode, though. While a few families appear to transmit the symptoms down in an autosomal dominant pattern, others appear to do so.
A single headache with at minimum one ipsilateral autonomic sign qualifies as a cluster headache. Up to 8 times per day, such headaches can happen every other day. They typically happen around the same hour of the day, most frequently during the night. The majority of patients experience repeated attacks for days to months at a time, accompanied by remissions lasting months or even years.
0.1 percent of the population in general experiences cluster headaches. Though it can begin at any age, the average age of onset is around 30. Although a recent study has revealed that the proportion has been declining with time, men are 3 times as likely as women to experience this illness.
This occurrence may be attributable to increased diagnostic performance; frequently, Horton’s syndrome is misdiagnosed in women as migraines. It’s interesting to note that tobacco users make up 85% of all cluster headache sufferers.
If a patient has a first-degree family who has been diagnosed with cluster headaches, their chances of getting one are increased by eighteen times. According to a wide range of research, between thirty and eighty percent of those who suffer from Horton’s syndrome have already sleep apnea.
Horton’s syndrome can have several different causes, as was already mentioned. There seems to be a diurnal regularity, which prompts research into the hypothalamus and, ultimately, morphological studies that reveal anomalies. The trigeminovascular network and parasympathetic nerve fibers are also involved.
Some studies have hypothesized that instability of the autonomic nervous system and a deficiency in the central route of pain control cause problems in the supraspinal control of cognitive processing and pain. Investigators also have discovered abnormalities in the GABA, ion channel, as well as inflammation-related molecular signaling pathways, particularly histamine, cell surface proteins, and Interleukin-2.
Given that pituitary adenylate cyclase-activating polypeptide (PCAP), rises in the blood throughout attacks, genetic testing has identified a number of potential sources, such as Period circadian protein homolog 3 protein (related to the circadian clock), orexin-B (related to the sleep-wake routine, modulation of nociceptive neurotransmission, and food consumption), and pituitary adenylate cyclase-activating Polypeptide receptor allele. All proposed genetic routes require further investigation.
Horton’s syndrome has an unclear cause. Numerous hypotheses have been put out and investigated. Sadly, sample sizes are constrained because people with this illness are rather uncommon. The parasympathetic nervous system responsible for the trigeminal-autonomic reflex pathway, the hypothalamus region, and the trigeminovascular system, are all known to be connected.
It is unclear how these components interact to produce severe headaches, though. The genetics of the illness has also been extensively studied, leading to a biochemical evaluation, because there is a clear genetic connection. A painful attack and vasodilation are inextricably linked. Perivascular sensory neurons generate widening of blood vessels (vasodilation) when the trigeminovascular system is activated.
The trigeminal nerve terminal is thought to be unilaterally activated; however functional MRI hasn’t shown this to be the case. Additionally, the number or duration of attacks is unaffected by a complete trigeminal nerve root division. This lack of improvement only demonstrates that there are other components to the cluster headache; it does not exclude the trigeminovascular system as a contributing factor.
Horton’s syndromes are definitely linked to the hypothalamic. Attacks occur most frequently at night and provide a circadian regularity. When the patient is experiencing an attack, PET (positron emission tomography) scans have revealed activity of the inferior hypothalamus grey volume. Studies on morphology have revealed anatomic irregularities in the same hypothalamic area.
However, it should be noted that activation of the hypothalamic does not cause attacks. Also, some studies point to the possibility that stimulating the hypothalamus could stop an attack.
The parasympathetic nerve fibers, which are a component of the trigeminal autonomic response, are what trigger the autonomic signs, such as rhinorrhea, lacrimation, and facial vasodilation. Similar to the hypothalamic, it is a well-known contributor to cluster headaches, however, it is unclear what causes the trigeminal reflex to activate.
Risk elements:
Gender male
Older than 30 years old
Alcohol consumption
Previous brain injury or surgery
Approximately twenty-five percent of people who get a cluster headache never get another one. About fifteen to twenty percent of individuals will experience chronic cluster headaches, and ten to twenty percent of these patients will become medication-resistant resistant. Usually, it takes this ailment fifteen years to get well.
Patients may suffer harm to their mental well-being. Physical burdens and a decline in quality of life will result. Suicidal ideation is frequently reported by patients, but actual action is uncommon.
Initial dose: 300mg subcutaneous at the onset of cluster headache
Maintenance dose: 300mg subcutaneously monthly once until the end of cluster headaches
Dose Adjustments
Hepatic impairment
No dedicated studies have been conducted to specifically evaluate the effects of hepatic impairment on the pharmacokinetics of galcanezumab
Renal impairment
No dedicated studies have been conducted to specifically evaluate the effects of hepatic impairment on the pharmacokinetics of galcanezumab
Indicated for prevention of cluster headache Take 4-8 mg as divided doses taken with food by oral route
https://www.ncbi.nlm.nih.gov/books/NBK544241/
medtigo
Cluster Headache
Updated :
June 27, 2022
Cluster headaches are also known as Horton’s syndrome. TACs (Trigeminal autonomic cephalgia), the major kind of headache, are most frequently manifested as cluster headaches. As just 0.1 percent of the population suffers from them, it is at best challenging to investigate the disease process. Considering their rarity, they should always be recognized and treated because they have established a reputation as being one of, but not the most serious forms of headaches.
Given that FDR (first-degree relatives) had an 18-fold increased risk of being diagnosed with Horton’s syndrome, there is some evidence of genetic correlation. Uncertainty surrounds the inheritance mode, though. While a few families appear to transmit the symptoms down in an autosomal dominant pattern, others appear to do so.
A single headache with at minimum one ipsilateral autonomic sign qualifies as a cluster headache. Up to 8 times per day, such headaches can happen every other day. They typically happen around the same hour of the day, most frequently during the night. The majority of patients experience repeated attacks for days to months at a time, accompanied by remissions lasting months or even years.
0.1 percent of the population in general experiences cluster headaches. Though it can begin at any age, the average age of onset is around 30. Although a recent study has revealed that the proportion has been declining with time, men are 3 times as likely as women to experience this illness.
This occurrence may be attributable to increased diagnostic performance; frequently, Horton’s syndrome is misdiagnosed in women as migraines. It’s interesting to note that tobacco users make up 85% of all cluster headache sufferers.
If a patient has a first-degree family who has been diagnosed with cluster headaches, their chances of getting one are increased by eighteen times. According to a wide range of research, between thirty and eighty percent of those who suffer from Horton’s syndrome have already sleep apnea.
Horton’s syndrome can have several different causes, as was already mentioned. There seems to be a diurnal regularity, which prompts research into the hypothalamus and, ultimately, morphological studies that reveal anomalies. The trigeminovascular network and parasympathetic nerve fibers are also involved.
Some studies have hypothesized that instability of the autonomic nervous system and a deficiency in the central route of pain control cause problems in the supraspinal control of cognitive processing and pain. Investigators also have discovered abnormalities in the GABA, ion channel, as well as inflammation-related molecular signaling pathways, particularly histamine, cell surface proteins, and Interleukin-2.
Given that pituitary adenylate cyclase-activating polypeptide (PCAP), rises in the blood throughout attacks, genetic testing has identified a number of potential sources, such as Period circadian protein homolog 3 protein (related to the circadian clock), orexin-B (related to the sleep-wake routine, modulation of nociceptive neurotransmission, and food consumption), and pituitary adenylate cyclase-activating Polypeptide receptor allele. All proposed genetic routes require further investigation.
Horton’s syndrome has an unclear cause. Numerous hypotheses have been put out and investigated. Sadly, sample sizes are constrained because people with this illness are rather uncommon. The parasympathetic nervous system responsible for the trigeminal-autonomic reflex pathway, the hypothalamus region, and the trigeminovascular system, are all known to be connected.
It is unclear how these components interact to produce severe headaches, though. The genetics of the illness has also been extensively studied, leading to a biochemical evaluation, because there is a clear genetic connection. A painful attack and vasodilation are inextricably linked. Perivascular sensory neurons generate widening of blood vessels (vasodilation) when the trigeminovascular system is activated.
The trigeminal nerve terminal is thought to be unilaterally activated; however functional MRI hasn’t shown this to be the case. Additionally, the number or duration of attacks is unaffected by a complete trigeminal nerve root division. This lack of improvement only demonstrates that there are other components to the cluster headache; it does not exclude the trigeminovascular system as a contributing factor.
Horton’s syndromes are definitely linked to the hypothalamic. Attacks occur most frequently at night and provide a circadian regularity. When the patient is experiencing an attack, PET (positron emission tomography) scans have revealed activity of the inferior hypothalamus grey volume. Studies on morphology have revealed anatomic irregularities in the same hypothalamic area.
However, it should be noted that activation of the hypothalamic does not cause attacks. Also, some studies point to the possibility that stimulating the hypothalamus could stop an attack.
The parasympathetic nerve fibers, which are a component of the trigeminal autonomic response, are what trigger the autonomic signs, such as rhinorrhea, lacrimation, and facial vasodilation. Similar to the hypothalamic, it is a well-known contributor to cluster headaches, however, it is unclear what causes the trigeminal reflex to activate.
Risk elements:
Gender male
Older than 30 years old
Alcohol consumption
Previous brain injury or surgery
Approximately twenty-five percent of people who get a cluster headache never get another one. About fifteen to twenty percent of individuals will experience chronic cluster headaches, and ten to twenty percent of these patients will become medication-resistant resistant. Usually, it takes this ailment fifteen years to get well.
Patients may suffer harm to their mental well-being. Physical burdens and a decline in quality of life will result. Suicidal ideation is frequently reported by patients, but actual action is uncommon.
https://www.ncbi.nlm.nih.gov/books/NBK544241/
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
